logo
Researchers discover why some people struggle to stay awake

Researchers discover why some people struggle to stay awake

Independent8 hours ago
Excessive Daytime Sleepiness (EDS), also known as hypersomnia, affects around one in four people in the UK.
New research suggests that diet and hormones may play a significant role in influencing a person's risk of developing EDS.
A study identified seven blood metabolites linked to EDS, with tyramine, found in fermented and overripe foods, specifically associated with increased drowsiness, particularly in men.
Conversely, omega-3 and omega-6 fatty acids, commonly found in Mediterranean -style diets, were linked to a lower risk of excessive sleepiness.
These findings point to potential treatment targets for EDS, including dietary changes and new medications, and distinguish the condition from simple tiredness, noting its links to other health issues such as a higher risk of cardiovascular disease, obesity and diabetes.
Why you're struggling to stay awake during the day - and how to feel more alert
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

A hearing aid before the age of 70 can dramatically reduce risk of dementia, new research finds
A hearing aid before the age of 70 can dramatically reduce risk of dementia, new research finds

The Independent

time8 minutes ago

  • The Independent

A hearing aid before the age of 70 can dramatically reduce risk of dementia, new research finds

People who use a hearing aid before the age of 70 can dramatically reduce their risk of dementia, new research shows. Dementia, which is the loss of cognitive functioning, affects more than six million Americans and leads to more than 100,000 deaths each year, according to the National Institutes of Health. As the U.S. population ages, dementia cases are expected to double by 2060, NIH says. Age-related hearing loss is a risk factor for developing dementia, and a research letter published in JAMA Neurology on Monday found that using hearing aids could reduce this risk. After studying nearly 3,000 participants over up to two decades researchers found those with hearing loss who used hearing aids had a 61 percent lower risk for dementia among those younger than 70 years at the time of their hearing loss diagnosis. 'This finding highlights the importance of early intervention for HL [hearing loss] for possible prevention of dementia,' the authors of the study wrote. But the study noted only 17 percent of people with moderate to severe hearing loss use hearing aids. UCLA Health gave three possible theories for the link between hearing loss and dementia including that hearing loss causes the brain to deteriorate faster. Additionally, your brain works harder to understand conversation when you can't hear well. Straining your brain regularly like this can impact your cognitive function. Hearing loss can also limit your social engagement as conversing in noisy environments is less enjoyable. Your brain may struggle to be intellectually stimulated without socialization. Age-related hearing loss affects one in three people older than 60, according to the American Academy of Audiology. One in two people older than the age of 85 has hearing loss. Common signs of hearing loss include asking people to repeat things, difficulty hearing and understanding speech in noisy settings, and turning the TV or radio up louder than normal. The American Academy of Audiology warns untreated hearing loss can be connected to cognitive decline as well as depression, anxiety, paranoia and poor social relationships.

Thousands of RAF air cadets will be offered training to be drone pilots
Thousands of RAF air cadets will be offered training to be drone pilots

The Sun

time9 minutes ago

  • The Sun

Thousands of RAF air cadets will be offered training to be drone pilots

THOUSANDS of RAF Air Cadets are to offered training to be drone pilots. Around 40,000 will have the chance to get qualified, in a move designed to boost job prospects in science and engineering while spotting future pilots. Courses recognised by the Civil Aviation Authority will be offered to all existing cadets. Alex Williamson, the head of Air Cadets drone training, said pupils that reach the top level would 'be able to walk straight into a job in industry'. Around a third of RAF cadets go on to careers in the military. Cadet Corporal Charlie Stewart, 15, said he now wants to be an RAF drone pilot after the training. He said: 'If we're going to be the best military, we're going to need the best drone pilots.' It comes as the Government has pledged £70million to recruit another 40,000 cadets across the RAF, Army and Navy over the next five years. It plans to increase total cadet numbers to 182,000 by 2030 to boost recruitment and links between the military and society. At the National Air & Space Camp in RAF Syerston, Newark, yesterday, veterans minister Al Carns said: 'The cadets provides children with experiences and opportunities, everything from leadership, Stem skills, teamwork, discipline, boundaries and principles. 'It's about preparing children for the challenges of later life." 1

Mysterious blue brain found in autopsy linked to RFK Jr's 'miracle cure'
Mysterious blue brain found in autopsy linked to RFK Jr's 'miracle cure'

Daily Mail​

time39 minutes ago

  • Daily Mail​

Mysterious blue brain found in autopsy linked to RFK Jr's 'miracle cure'

A substance touted by health secretary Robert F Kennedy Jr as a 'miracle cure-all' has been found to dramatically change the color of internal organs, according to a new study. Researchers at University Hospital Frankfurt in Germany examined the bodies of 11 people and discovered that methylene blue, a synthetic dye long used to treat conditions like malaria and methemoglobinemia. Methylene blue may also help combat other health problems, including urinary tract infections and depression, experts have said. During the autopsies, researchers discovered that the brains, hearts, lungs, and pancreases had turned a striking shade of blue. Even small doses, as little as 25 milligrams, roughly a quarter of a standard aspirin tablet, were enough to alter brain pigment, the team concluded. Some individuals had received 50 to 200 milligrams intravenously for medical conditions, with multiple doses given within 10 hours of death, and all showed discoloration of the brain and heart. The researchers emphasized that while the color changes darkened upon exposure to air during autopsies, the effect was not linked to the causes of death. Instead, it highlights how methylene blue persists in the body and can dramatically affect organ appearance, raising questions for forensic and medical examinations. The individuals who received methylene blue in the hospital were generally being treated for severe medical conditions, often involving life-threatening shock or critical illnesses. Most were in intensive care units (ICUs) for issues like septic shock from infections, heart failure, complications following surgeries, or severe COVID-19 infections. Hospital staff administered the dye intravenously as a last-resort treatment to improve blood flow and oxygen delivery when standard treatments failed. The startling discovery, published in the journal Forensic Science, Medicine and Pathology, was made while researchers were conducting an autopsy on a 72-year-old man and found his brain was blue. To understand why, they searched their institute's database of 15,820 autopsy records from 2000 to 2023, looking for similar cases of doctors finding 'blue-green,' 'greenish,' or 'turquoise' organs during autopsies. They found 11 cases, including the 72-year-old, where various organs throughout the body had this unusual color. In each case, they found that six of these individuals with blue organs had ingested or been given a dosage of methylene blue shortly before their deaths. The other five had received or ingested a medical dye called toluidine blue, a sedative called Rohypnol that contains the blue dye indigocarmine, or a cleaning agent with the blue dye Brilliant Blue FCF. Study authors in Germany found 6 people who received dosages of methylene blue while in the hospital had blue brains and hearts after death The patients had taken the medical dye as a last resort treatment for various illnesses, including COVID-19 Although RFK Jr has not publicly confirmed that he uses methylene blue, a February 2025 video showed the health secretary putting droplets of a cobalt-blue liquid into what looked like water. Recent studies have explored its use in fighting early-stage COVID-19 by potentially reducing viral damage and improving oxygen delivery. It's also been investigated for its ability to boost brain health, treat shock, and potentially as an anti-aging serum. Some research has even suggested it can kill cancer cells under specific conditions. In fact, actor Mel Gibson claimed three of his friends recovered from stage four cancer after taking a supplement regimen that included methylene blue. In fact, actor Mel Gibson claimed three of his friends recovered from stage four cancer after taking a supplement regimen that included methylene blue. The Daily Mail has requested a comment from RFK Jr and the Department of Health and Human Services about the findings and is awaiting a response. While medical professionals only use the dye in extreme cases, methylene blue has taken over TikTok and Instagram with claims it can sharpen focus and boost mood. Methylene blue is FDA approved to treat the rare blood disorder methemoglobinemia, though it has also been used off label for anti-aging and cancer Influencers have dubbed it 'brain fuel' and a 'limitless pill,' with some studies claiming it can also alleviate mental health issues. However, neuroscientist Anne-Sophie Fluri told the Daily Mail in June that many of the supposed benefits being promoted online are based on preliminary research using rodents or petri dishes, not conclusive human clinical trials. The US Food and Drug Administration (FDA) has issued a public safety warning about methylene blue's potential to cause serotonin syndrome when combined with common antidepressants like Prozac, Zoloft, or Cymbalta. Serotonin syndrome is a dangerous condition caused by too much serotonin in the body, leading to symptoms like confusion, high fever, seizures, and, in rare cases, death. Methylene blue can trigger this syndrome when taken with antidepressants because it blocks an enzyme that normally breaks down serotonin, causing a harmful buildup.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store